Polomar Health Services (PMHS) Revenue (2022 - 2026)
Polomar Health Services (PMHS) posted Revenue of $1.5 million for Q2 2026, up 52.03% on a QoQ basis from $1.0 million in Q1 2026, and up 27847.07% year-over-year from N/an in Q2 2025.
Analysis
Polomar Health Services (PMHS) Revenue (2022 - 2026) Analysis & Trends
Polomar Health Services has reported Revenue for 5 years, with the latest figure at $1.5 million in Q2 2026.
- On a quarterly basis, Revenue rose 27847.07% year-over-year to $1.5 million in Q2 2026; TTM through Jun 2026 was $3.2 million, a 7688.77% increase from a year earlier, with the FY2025 full-year figure at $648231.0, up 1001.98% from the prior year.
- Revenue was $1.5 million for Q2 2026 at Polomar Health Services, up from $1.0 million in the prior quarter.
- The five-year high for Revenue was $1.5 million in Q2 2026, with the low at $4526.0 in Q3 2022.
- Average Revenue over 5 years is $236753.6, with a median of $15891.5 recorded in 2023.
- The sharpest annual moves came in 2025 and 2026: Revenue tumbled 66.63% in 2025, then soared 27847.07% in 2026.
- Over 5 years, Revenue stood at $30000.0 in 2022, then plunged by 42.37% to $17288.0 in 2023, then gained by 20.72% to $20870.0 in 2024, then soared by 2928.54% to $632057.0 in 2025, then surged by 141.86% to $1.5 million in 2026.
- The last three Revenue figures came in at $1.5 million (Q2 2026), $1.0 million (Q1 2026), and $632057.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 4.14 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 3.76 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 852.47 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 796.20 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 2.85 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 54.76 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 266.04 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 183.90 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 17.87 Mn |
| 10 | Polomar Health Services | 5.66 Mn | 5.48 Mn | 935,916.00 | 1.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.53 Mn |
| Mar 31, 2026 | 1.01 Mn |
| Dec 31, 2025 | 632,057.00 |
| Sep 30, 2025 | 6,163.00 |
| Jun 30, 2025 | 5,470.00 |
| Mar 31, 2025 | 4,542.00 |
| Dec 31, 2024 | 20,870.00 |
| Sep 30, 2024 | 9,849.00 |
| Jun 30, 2024 | 14,495.00 |
| Mar 31, 2024 | 13,610.00 |
| Dec 31, 2023 | 17,288.00 |
| Sep 30, 2023 | 21,457.00 |
| Dec 31, 2022 | 30,000.00 |
| Sep 30, 2022 | 4,526.00 |